NO20091955L - Antivirale sammensetninger, og fremgangsmater for anvendelse - Google Patents

Antivirale sammensetninger, og fremgangsmater for anvendelse

Info

Publication number
NO20091955L
NO20091955L NO20091955A NO20091955A NO20091955L NO 20091955 L NO20091955 L NO 20091955L NO 20091955 A NO20091955 A NO 20091955A NO 20091955 A NO20091955 A NO 20091955A NO 20091955 L NO20091955 L NO 20091955L
Authority
NO
Norway
Prior art keywords
methods
antiviral compositions
antiviral
compositions
lambdacarrageenan
Prior art date
Application number
NO20091955A
Other languages
English (en)
Other versions
NO342681B1 (no
Inventor
Andreas Grassauer
Eva Prieschl-Grassauer
Christiane Meier
Alexander Pretsch
Original Assignee
Marinomed Biotechnologie Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/567,078 external-priority patent/US20080131454A1/en
Priority claimed from EP06450176A external-priority patent/EP1930015A1/en
Application filed by Marinomed Biotechnologie Gmbh filed Critical Marinomed Biotechnologie Gmbh
Publication of NO20091955L publication Critical patent/NO20091955L/no
Publication of NO342681B1 publication Critical patent/NO342681B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/731—Carrageenans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Paper (AREA)

Abstract

Det beskrives anvendelse av iota-, kappa- eller lambda karrageenan eller blandinger derav for fremstilling av en antiviral farmasøytisk sammensetning for 5 profylakse eller behandling av en rinovirusinfeksjon.
NO20091955A 2006-12-05 2009-05-20 Anvendelse av iota-karragenan for behandling av rinovirusinfeksjon NO342681B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11/567,078 US20080131454A1 (en) 2006-12-05 2006-12-05 Methods and Compositions for the Treatment of Rhinovirus Infections with Carrageenan
EP06450176A EP1930015A1 (en) 2006-12-05 2006-12-05 Use of carrageenan for treating rhinovirus infections
PCT/EP2007/010512 WO2008067982A2 (en) 2006-12-05 2007-12-04 Use of carrageenan for treating rhinovirus infections

Publications (2)

Publication Number Publication Date
NO20091955L true NO20091955L (no) 2009-09-04
NO342681B1 NO342681B1 (no) 2018-07-02

Family

ID=39383268

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20091955A NO342681B1 (no) 2006-12-05 2009-05-20 Anvendelse av iota-karragenan for behandling av rinovirusinfeksjon

Country Status (24)

Country Link
EP (1) EP2101792B1 (no)
JP (1) JP5470047B2 (no)
KR (1) KR101437708B1 (no)
CN (1) CN101678040B (no)
AT (1) ATE462438T1 (no)
AU (1) AU2007327934B2 (no)
BR (1) BRPI0720054A2 (no)
CA (1) CA2671317C (no)
CY (1) CY1110658T1 (no)
DE (1) DE602007005697D1 (no)
DK (1) DK2101792T3 (no)
EA (1) EA015930B1 (no)
ES (1) ES2343701T3 (no)
HK (1) HK1141980A1 (no)
IL (1) IL198810A (no)
MA (1) MA31145B1 (no)
MX (1) MX2009005838A (no)
NO (1) NO342681B1 (no)
NZ (1) NZ577063A (no)
PL (1) PL2101792T3 (no)
PT (1) PT2101792E (no)
SI (1) SI2101792T1 (no)
TN (1) TN2009000211A1 (no)
WO (1) WO2008067982A2 (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5687619B2 (ja) * 2008-07-01 2015-03-18 マリノメド バイオテクノロジー ゲゼルシャフト ミット ベシュレンクテル ハフツング 抗アレルギー性の海洋性バイオポリマー
JP5702526B2 (ja) * 2009-04-30 2015-04-15 Ｅｓファイバービジョンズ株式会社 抗ウイルス性を有する硫酸化セルロースを担持させた繊維集合体
EP2515889B1 (en) 2009-12-22 2014-12-10 Marinomed Biotechnologie GmbH Synergistic antiviral composition and use thereof
JP5900030B2 (ja) 2011-03-08 2016-04-06 凸版印刷株式会社 防湿容器
ES2734269T3 (es) * 2014-01-22 2019-12-05 Visufarma B V Composición que comprende carragenina tipo iota contra conjuntivitis viral
HUE062108T2 (hu) 2015-07-14 2023-09-28 Marinomed Biotech Ag Vírusellenes hatású, orrdugulást megszûntetõ készítmény
UA118192C2 (uk) * 2015-10-22 2018-12-10 Юрій Захарович Толчеєв Противірусна фармацевтична композиція
KR102316819B1 (ko) * 2018-04-20 2021-10-25 한미약품 주식회사 카라기난을 유효성분으로 포함하는 보존성이 개선된 액상 제제
KR101995376B1 (ko) * 2018-08-20 2019-07-02 한미약품 주식회사 카라기난을 유효성분으로 포함하는 항-바이러스 조성물
CN111437270A (zh) * 2020-04-24 2020-07-24 瑞希(重庆)生物科技有限公司 一种卡拉胶鼻用即型凝胶喷雾剂及其制备方法
KR20230094472A (ko) * 2021-12-21 2023-06-28 (주)메디코어 비강 세정제 조성물 및 그 제조방법

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7958701A (en) 2000-07-28 2002-02-13 Immupharm Aps Method of treating symptoms of common cold, allergic rhinitis and infections relating to the respiratory tract
US6953483B2 (en) * 2002-03-05 2005-10-11 Litke Kenneth S Aloe vera processed leather and leather gloves, garments, shoes and sandals made from aloe vera processed leather and a process for making aloe vera processed leather
WO2003093322A2 (en) * 2002-04-30 2003-11-13 The Population Council, Inc. Carrageenan based antimicrobial compositions
CN1194981C (zh) * 2002-07-22 2005-03-30 青岛海洋大学 卡拉胶低聚糖的制备方法
CN100435805C (zh) * 2003-05-26 2008-11-26 福州大学 多糖硫酸酯作为制备抗流感病毒药物的应用
US20050009782A1 (en) * 2003-07-09 2005-01-13 Comper Wayne D. Antiviral charged polymers that exhibit resistance to lysosomal degradation during kidney filtration and renal passage, compositions and methods of use thereof
US20080004236A1 (en) * 2004-02-06 2008-01-03 Comper Wayne D High Dose, Short Interval Use of Sulfated Polysaccharides for Treatment of Infections
DE202005014019U1 (de) 2005-09-05 2005-11-24 G. Pohl-Boskamp Gmbh & Co. Kg Zubereitung zum Ersatz von Speichelflüssigkeit und zur Pflege bei Trockenheit der Mund- und Rachenschleimhäute
ITRM20060115A1 (it) * 2006-03-06 2006-06-05 Paolo Ottier Guanto costituito da tre strati sovrapposti di poliuretano di cui due a tenuta stagna contenenti olio lubrificante per la parpazione del seno femminile
DE102006031812A1 (de) 2006-07-07 2008-01-17 Leoni Ag Sensorsystem und Sensorelement

Also Published As

Publication number Publication date
NO342681B1 (no) 2018-07-02
CN101678040B (zh) 2012-10-03
EP2101792B1 (en) 2010-03-31
CA2671317C (en) 2015-03-17
WO2008067982A3 (en) 2009-04-16
TN2009000211A1 (en) 2010-10-18
KR20090096598A (ko) 2009-09-11
DE602007005697D1 (de) 2010-05-12
MX2009005838A (es) 2009-06-16
NZ577063A (en) 2011-05-27
IL198810A0 (en) 2010-02-17
AU2007327934B2 (en) 2013-04-18
JP2010512307A (ja) 2010-04-22
CY1110658T1 (el) 2015-06-10
CA2671317A1 (en) 2008-06-12
HK1141980A1 (en) 2010-11-26
DK2101792T3 (da) 2010-07-26
ATE462438T1 (de) 2010-04-15
WO2008067982A2 (en) 2008-06-12
EP2101792A2 (en) 2009-09-23
EA200970529A1 (ru) 2009-12-30
IL198810A (en) 2013-03-24
JP5470047B2 (ja) 2014-04-16
KR101437708B1 (ko) 2014-09-03
BRPI0720054A2 (pt) 2013-12-17
MA31145B1 (fr) 2010-02-01
ES2343701T3 (es) 2010-08-06
AU2007327934A1 (en) 2008-06-12
PT2101792E (pt) 2010-06-25
CN101678040A (zh) 2010-03-24
PL2101792T3 (pl) 2010-11-30
EA015930B1 (ru) 2011-12-30
SI2101792T1 (sl) 2010-08-31

Similar Documents

Publication Publication Date Title
NO20091955L (no) Antivirale sammensetninger, og fremgangsmater for anvendelse
CY1118523T1 (el) Πεπτιδικες ενωσεις για την θεραπεια του ανθεκτικου status epilepticus
DK1853602T3 (da) Kemiske forbindelser
DK1853588T3 (da) Kemiske forbindelser
CY1108843T1 (el) 3,11β cis διϋδροτετραβεναζινη για την θεραπεια της σχιζοφρενιας και αλλων ψυχωσεων
CY1111454T1 (el) Παραγωγα φαινυλο-πυραζολιου ως συνδετες υποδοχεα μη στεροειδων γλυκοκορτικοειδων
CL2011000691A1 (es) Compuestos derivados de nicotinamida sustituida; composicion farmaceutica que los comprende; uso para el tratamiento y/o prevencion de cancer, infecciones, enfermedades inflamatorias y autoinmunitarias.
ATE528989T1 (de) Kristalline feste rasagilin-base
SE0301700D0 (sv) Novel compounds
MX2010007936A (es) Anticuerpo anti-nr-10 y su uso.
MX2009004707A (es) Piridina carboxamides como inhibidores 11-beta-hsd1.
EA200801997A1 (ru) Новые соединения
NO20082120L (no) Behandling og forebyggelse av mikroangiopati
CL2007002890A1 (es) Compuestos derivados de 2-piridincarboxamida, activador de glucosinasa; composicion farmaceutica; y uso del compuesto para el tratamiento de diabetes o la obesidad.
LTC2805723I2 (lt) Kladribino režimas, skirtas išsėtinei sklerozei gydyti
ATE554084T1 (de) N-hydroxyacrylamidverbindungen
ATE380188T1 (de) Substituierte chinolone
BRPI0509667A (pt) azaquinazolinas substituìdas com eficácia antiviral
TW200621260A (en) Selected fused heterocyclics and uses thereof
UA94781C2 (ru) Применение йота-каррагенана для профилактики или терапевтического лечения риновирусной инфекции
ATE524488T1 (de) Lysobactinamide
CL2008002223A1 (es) Compuestos derivados de 9-desoxo-9a-metil-9a-aza-9a-homoeritromicina a 2'-o-sustituida; proceso de preparación; compuesto intermediario; composición farmacéutica; y su uso en el tratamiento y/o profilaxis de la malaria.
ATE475424T1 (de) Cellulosesulfat zur behandlung von rhinovirus- infektionen
ATE553088T1 (de) Substituierte chinolone ii
ATE482198T1 (de) Sitamaquintosylat zur behandlung von leishmaniase